Notably, a significant positive relationship was observed between AKAP12 and IC50 values of sorafenib in lung cancer (Figure 1I), primary pan-cancer (Figure 1J), and metastasis pan-cancer (Figure 1K). This evidence concerns the gene AKAP12 and lung carcinoma.